Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial

Lifestyle Intervention ◽

Controlled Trial ◽

Early Type ◽

Open Label ◽

Intensive Lifestyle Intervention ◽

Parallel Group ◽

Review for "Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: results of a multicentre, open‐label, randomised controlled trial (BEYOND VII)"

10.1111/dom.13967/v1/review6 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Starting Dose ◽

Review for "Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: results of a multicentre, open‐label, randomised controlled trial (BEYOND VII)"

10.1111/dom.13967/v1/review4 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Starting Dose ◽

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(19)30184-6 ◽

2019 ◽

Vol 7 (8) ◽

pp. 596-605 ◽

Cited By ~ 15

Author(s):

Vanita R Aroda ◽

Guillermo González-Galvez ◽

Randi Grøn ◽

Natalie Halladin ◽

Martin Haluzík ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Insulin Degludec ◽

Open Label ◽

Open Label Phase ◽

Review for "Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: results of a multicentre, open‐label, randomised controlled trial (BEYOND VII)"

10.1111/dom.13967/v2/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Starting Dose ◽

Review for "Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: results of a multicentre, open‐label, randomised controlled trial (BEYOND VII)"

10.1111/dom.13967/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Starting Dose ◽

Review for "Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: results of a multicentre, open‐label, randomised controlled trial (BEYOND VII)"

10.1111/dom.13967/v1/review8 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Starting Dose ◽

Decision letter for "Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: results of a multicentre, open‐label, randomised controlled trial (BEYOND VII)"

10.1111/dom.13967/v1/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Starting Dose ◽

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(17)30327-3 ◽

2017 ◽

Vol 5 (12) ◽

pp. 951-964 ◽

Cited By ~ 87

Author(s):

Kohjiro Ueki ◽

Takayoshi Sasako ◽

Yukiko Okazaki ◽

Masayuki Kato ◽

Sumie Okahata ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Cardiovascular Outcomes ◽

Multifactorial Intervention ◽

Open Label ◽

Long-term effect of smartphone-delivered Interval Walking Training on physical activity in patients with type 2 diabetes: protocol for a parallel group single-blinded randomised controlled trial

BMJ Open ◽

10.1136/bmjopen-2016-014036 ◽

2017 ◽

Vol 7 (4) ◽

pp. e014036 ◽

Cited By ~ 5

Author(s):

Laura Staun Valentiner ◽

Mathias Ried-Larsen ◽

Kristian Karstoft ◽

Cecilie Fau Brinkløv ◽

Charlotte Brøns ◽

...

Keyword(s):

Physical Activity ◽

Type 2 Diabetes ◽

Controlled Trial ◽

Term Effect ◽

Long Term Effect ◽

Parallel Group ◽

The effect of a cinnamon-, chromium- and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: an open-label cross-over randomised controlled trial

European Journal of Nutrition ◽

10.1007/s00394-015-0926-x ◽

2015 ◽

Vol 55 (3) ◽

pp. 1123-1131 ◽

Cited By ~ 25

Author(s):

Patricia Whitfield ◽

Amber Parry-Strong ◽

Emily Walsh ◽

Mark Weatherall ◽

Jeremy D. Krebs

Keyword(s):

Type 2 Diabetes ◽

Weight Loss ◽

Glycaemic Control ◽

Controlled Trial ◽

Open Label ◽

Randomised Controlled ◽

Lipid Parameters